Drug may reduce coronary artery plaque

Oct 12, 2008

Research presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF), suggests that olmesartan, a drug commonly used to treat high blood pressure, may play a role in reducing coronary plaque.

The trial, "Impact of OLmesartan on progression of coronary atherosclerosis; evaluation by IVUS [OLIVUS], was performed on 247 angina patients with native coronary artery lesions. Patients were randomly assigned to receive 20-40mg/day of olmesartan or control, and treated with a combination of β-blockers, calcium channel blockers, diuretics, nitrates, glycemic control agents and/or statins per physician's guidance.

Serial Intravenous Ultrasound (IVUS) examinations were performed to assess the amount of coronary plaque before and 14 months after the start of treatment.

At the start of the trial, patient characteristics and all IVUS measurements were identical between the two groups. However, after 14 months of treatment, IVUS showed significant decreases in measurements of plaque volume in the olmesartan group, despite similar blood pressure readings.

In addition, multivariate analysis identified olmesartan administration as one of the factors that caused the decrease in plaque volume.

"Management of plaque is a key front in the war on sudden heart attack," said Atsushi Hirohata, M.D, Ph.D, Cardiovascular Medicine, the Sakakibara Heart Institute of Okayama, Okayama, Japan and lead author of the study. "These results suggest a positive role in potential plaque regression through the administration of olmesartan, an angiotension-II receptor blocking agent, for patients with stable angina pectoris."

Source: Cardiovascular Research Foundation

Explore further: FDA panel rejects combination pain pill

add to favorites email to friend print save as pdf

Related Stories

Spying on plant communication with tiny bugs

4 minutes ago

Internal communications in plants share striking similarities with those in animals, new research reveals. With the help of tiny insects, scientists were able to tap into this communication system. Their ...

On global warming, settled science and George Brandis

24 minutes ago

The Australian Attorney General, Senator George Brandis is no stranger to controversy. His statement in parliament that "people do have a right to be bigots" rapidly gained him notoriety, and it isn't hard to understand why ...

Recommended for you

FDA proposes accelerated medical device approval plan

6 hours ago

(HealthDay)—The U.S. Food and Drug Administration has proposed a new program that would provide expedited access to high-risk medical devices intended for patients with serious conditions whose medical ...

Targeting drugs to reduce side effects

12 hours ago

(Medical Xpress)—Consider ice cream – the base of which is frozen cream. Ingredients are then added to make different flavours. All these flavours are distinctly different but are created from the same foundation.

User comments : 0

More news stories